Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ekso Bionics Holdings (EKSO) Shares Issued (2016 - 2025)

Ekso Bionics Holdings has reported Shares Issued over the past 12 years, most recently at $24000.0 for Q3 2025.

  • On a quarterly basis, Shares Issued fell 99.52% to $24000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 197.71% increase, with the full-year FY2025 number at $3.9 million, changed N/A from a year prior.
  • Shares Issued reached $24000.0 in Q3 2025 per EKSO's latest filing, down from $3.9 million in the prior quarter.
  • The five-year high for Shares Issued was $35.9 million in Q3 2021, with the low at -$9.0 million in Q4 2024.
  • The 4-year median for Shares Issued is $1.0 million (2021), against an average of $4.7 million.
  • Peak YoY movement for Shares Issued: tumbled 1464.75% in 2024, then soared 8282.61% in 2025.
  • Tracing EKSO's Shares Issued over 4 years: stood at $35.9 million in 2021, then plummeted by 98.16% to $661000.0 in 2023, then tumbled by 1464.75% to -$9.0 million in 2024, then surged by 100.27% to $24000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $24000.0, $3.9 million, and -$9.0 million for Q3 2025, Q2 2025, and Q4 2024 respectively.